Association Between Administration of Dexmedetomidine and Postoperative Mortality in Hospitals

NCT06248346 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 518043

Last updated 2024-02-08

No results posted yet for this study

Summary

The present multicentre retrospective cohort study aimed to investigate the association between intraoperative administration of dexmedetomidine and postoperative mortality in hospitals.

The investigators set out to test the hypothesis that perioperative dexmedetomidine use, as an adjunct to general anesthesia, diminishes postoperative mortality in hospitals across all categories of surgical patients.

Conditions

  • In-hospital Mortality

Interventions

DRUG

Dexmedetomidine

whether intraoperative dexmedetomidine was administered adjunct to propofol for patients undergoing surgeries under general anaesthesia

Sponsors & Collaborators

  • The Affiliated Hospital of Qingdao University

    collaborator OTHER
  • First Hospital of China Medical University

    collaborator OTHER
  • The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School

    collaborator OTHER
  • Sir Run Run Shaw Hospital

    collaborator OTHER
  • Xijing Hospital

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-09-01
Primary Completion
2018-06-30
Completion
2018-07-01

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06248346 on ClinicalTrials.gov